Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid EverBank Financial Corp (EVER)?

Page 1 of 2

Is it smart to be bullish on EverBank Financial Corp (NYSE:EVER)?

In the 21st century investor’s toolkit, there are dozens of indicators market participants can use to analyze stocks. Two of the most useful are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best investment managers can outperform the market by a significant amount (see just how much).

Just as useful, positive insider trading sentiment is another way to look at the stock market universe. There are plenty of motivations for an executive to drop shares of his or her company, but just one, very simple reason why they would buy. Plenty of empirical studies have demonstrated the valuable potential of this method if investors understand where to look (learn more here).

EverBank Financial Corp (NYSE:EVER)

Furthermore, we’re going to study the recent info about EverBank Financial Corp (NYSE:EVER).

How have hedgies been trading EverBank Financial Corp (NYSE:EVER)?

At Q2’s end, a total of 9 of the hedge funds we track held long positions in this stock, a change of -10% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were upping their holdings meaningfully.

When using filings from the hedgies we track, Edward Gilhuly and Scott Stuart’s Sageview Capital had the most valuable position in EverBank Financial Corp (NYSE:EVER), worth close to $213.8 million, comprising 58.1% of its total 13F portfolio. Coming in second is Steven B. Klinsky of New Mountain Capital, with a $144.7 million position; the fund has 80.7% of its 13F portfolio invested in the stock. Other peers that hold long positions include Tom Brown’s Second Curve Capital, Jim Simons’s Renaissance Technologies and David Costen Haley’s HBK Investments.

As EverBank Financial Corp (NYSE:EVER) has faced declining interest from the top-tier hedge fund industry, logic holds that there were a few hedge funds who sold off their entire stakes in Q1. Intriguingly, Anand Parekh’s Alyeska Investment Group sold off the largest investment of the “upper crust” of funds we track, valued at close to $1.6 million in call options., and Ken Griffin of Citadel Investment Group was right behind this move, as the fund said goodbye to about $0.8 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest dropped by 1 funds in Q1.

What do corporate executives and insiders think about EverBank Financial Corp (NYSE:EVER)?

Insider buying is most useful when the company in question has seen transactions within the past 180 days. Over the latest half-year time frame, EverBank Financial Corp (NYSE:EVER) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to EverBank Financial Corp (NYSE:EVER). These stocks are IBERIABANK Corporation (NASDAQ:IBKC), BancorpSouth, Inc. (NYSE:BXS), Bank Of The Ozarks Inc (NASDAQ:OZRK), Trustmark Corp (NASDAQ:TRMK), and F.N.B. Corp (NYSE:FNB). This group of stocks belong to the regional – southeast banks industry and their market caps match EVER’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!